These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 25400771

  • 21. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
    Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
    [Abstract] [Full Text] [Related]

  • 22. PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
    Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Zhu L, Zeng H, Schell TD, Zheng H.
    Blood Cancer J; 2015 Jul 31; 5(7):e330. PubMed ID: 26230954
    [Abstract] [Full Text] [Related]

  • 23. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M, Zhang C, Tian T, Zhang T, Wang R, Han F, Zhong C, Hua M, Ma D.
    Front Immunol; 2018 Jul 31; 9():1274. PubMed ID: 29922294
    [Abstract] [Full Text] [Related]

  • 24. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Oct 31; 44(10):2038-46. PubMed ID: 23701943
    [Abstract] [Full Text] [Related]

  • 25. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM.
    Hematology; 2014 Jan 31; 19(1):22-30. PubMed ID: 23540998
    [Abstract] [Full Text] [Related]

  • 26. Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
    Dama P, Tang M, Fulton N, Kline J, Liu H.
    J Immunother Cancer; 2019 Jul 10; 7(1):175. PubMed ID: 31291985
    [Abstract] [Full Text] [Related]

  • 27. Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.
    Tang L, Wu J, Li CG, Jiang HW, Xu M, Du M, Yin Z, Mei H, Hu Y.
    Clin Cancer Res; 2020 Apr 01; 26(7):1763-1772. PubMed ID: 31911547
    [Abstract] [Full Text] [Related]

  • 28. Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis.
    Li S, Peng D, He Y, Zhang H, Sun H, Shan S, Song Y, Zhang S, Xiao H, Song H, Zhang M.
    APMIS; 2014 Oct 01; 122(10):899-904. PubMed ID: 24689929
    [Abstract] [Full Text] [Related]

  • 29. Acute myeloid leukemia: 2013 update on risk-stratification and management.
    Estey EH.
    Am J Hematol; 2013 Apr 01; 88(4):318-27. PubMed ID: 23526416
    [Abstract] [Full Text] [Related]

  • 30. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.].
    Xu B, Shi PC, Song XY, Tang JH, Zhou SY.
    Ai Zheng; 2009 Jun 01; 28(6):632-6. PubMed ID: 19635202
    [Abstract] [Full Text] [Related]

  • 31. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
    Wang YG, Liu XH, Liang Y, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov 01; 29(11):741-5. PubMed ID: 19176010
    [Abstract] [Full Text] [Related]

  • 32. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J, Cooperative AML group CETLAM.
    Oncotarget; 2015 Oct 13; 6(31):31613-27. PubMed ID: 26436590
    [Abstract] [Full Text] [Related]

  • 33. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, Flores W, Bueso-Ramos C, Blando J, Galera P, Calvo KR, Al-Atrash G, Allison JP, Kantarjian HM, Sharma P, Daver NG.
    Cancer; 2019 May 01; 125(9):1470-1481. PubMed ID: 30500073
    [Abstract] [Full Text] [Related]

  • 34. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
    Huang S, Zhao Y, Lai W, Tan J, Zheng X, Zha X, Li Y, Chen S.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2278229. PubMed ID: 37962843
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of FLT3 internal tandem duplication in egyptian patients with acute myeloid leukemia with normal or favorable risk cytogenetics.
    Shahin D, Aly R, Ebrahim MA.
    Egypt J Immunol; 2010 Dec 31; 17(2):23-32. PubMed ID: 23082484
    [Abstract] [Full Text] [Related]

  • 36. [Detection and clinical significance of FLT3-ITD gene mutation in patients with acute myeloid leukemia].
    Xu YY, Gao L, Ding Y, Sun JZ, Wang N, Wang LL, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec 31; 20(6):1312-5. PubMed ID: 23257423
    [Abstract] [Full Text] [Related]

  • 37. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
    Hao S, Shao Z.
    Int J Clin Exp Pathol; 2015 Dec 31; 8(6):7223-8. PubMed ID: 26261618
    [Abstract] [Full Text] [Related]

  • 38. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q.
    Am J Clin Pathol; 2008 Apr 31; 129(4):624-9. PubMed ID: 18343790
    [Abstract] [Full Text] [Related]

  • 39. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L, Chen R, Zhang Y, Fan W, Xiao F, Yan X.
    Diagn Pathol; 2015 Jul 17; 10():109. PubMed ID: 26185105
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia.
    Wang J, Yang L, Dao FT, Wang YZ, Chang Y, Xu N, Chen WM, Jiang Q, Jiang H, Liu YR, Qin YZ.
    Leuk Lymphoma; 2022 Jan 17; 63(1):152-161. PubMed ID: 34405769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.